Zhu et al. 30 found that a hypoxic TME could activate the HIF-1α/VEGF pathway to improve lung cancer cell viability, inhibit apoptosis, and promote angiogenesis and resistance to radiotherapy, leading to a poorer prognosis, while inhibition of this pathway could reverse this process. Here, VEGFA is linked to lung cancer.